---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-084266"
form_type: "8-K"
ticker: "NAMS"
cik: "0001936258"
company_name: "NewAmsterdam Pharma Co N.V."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:49:16.967226+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# NewAmsterdam Pharma files updated corporate presentation, no specific details disclosed

## Summary
- Company posted an updated investor presentation on its website on March 2, 2026.
- Presentation furnished as Exhibit 99.1 to this Form 8-K but not reproduced in available text.
- No financial or operational updates explicitly provided in the filing text.
- Content of the presentation is unknown; cannot extract specific numbers or events.
- Confidence low due to lack of exhibit content and absence of material disclosures.

## SEC filing metadata
- accession: 0001193125-26-084266
- form_type: 8-K
- ticker: NAMS
- cik: 0001936258
- company_name: NewAmsterdam Pharma Co N.V.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1936258/000119312526084266/0001193125-26-084266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1936258/000119312526084266/nams-20260302.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-084266
- JSON: https://secwatch.observer/filing/0001193125-26-084266.json
- Plain text: https://secwatch.observer/filing/0001193125-26-084266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.